Region:Middle East
Author(s):Shubham
Product Code:KRAD3576
Pages:80
Published On:November 2025
 Market.png)
By Type:The CABG market can be segmented into various types, including On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG (MIDCAB), Hybrid Coronary Revascularization, and Others. Among these, Off-pump CABG is currently the most widely used technique in the Middle East, accounting for the largest market share. This method avoids the use of a heart-lung machine, reducing complications and recovery time for certain patient groups. The growing preference for off-pump procedures is driven by clinical outcomes and the expertise of surgical teams in the region .

By End-User:The CABG market is segmented by end-users, including Hospitals, Cardiac specialty centers, Ambulatory surgical centers, and Others. Hospitals remain the leading end-user segment, primarily due to their comprehensive facilities and resources to perform complex surgeries. They are equipped with advanced technology and skilled personnel, making them the preferred choice for patients requiring CABG. The increasing number of hospitals investing in cardiac care and the expansion of tertiary care centers further solidify their dominance in this segment .

The Middle East Coronary Artery Bypass Graft (CABG) Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, Johnson & Johnson (Ethicon/Cardiovascular & Specialty Solutions), Stryker Corporation, B. Braun Melsungen AG, Cook Medical LLC, Siemens Healthineers AG, Philips Healthcare (Royal Philips NV), GE HealthCare Technologies Inc., Canon Medical Systems Corporation, Getinge AB, LivaNova PLC contribute to innovation, geographic expansion, and service delivery in this space.
The future of the CABG market in the Middle East appears promising, driven by ongoing advancements in medical technology and an increasing focus on patient-centered care. As healthcare systems invest in expanding surgical facilities and integrating telemedicine, the accessibility and efficiency of CABG procedures are expected to improve. Additionally, the growing trend towards outpatient surgeries will likely reshape patient experiences, making CABG a more attractive option for those in need of cardiac interventions.
| Segment | Sub-Segments |
|---|---|
| By Type | On-pump CABG Off-pump CABG Minimally Invasive Direct CABG (MIDCAB) Hybrid Coronary Revascularization Others |
| By End-User | Hospitals Cardiac specialty centers Ambulatory surgical centers Others |
| By Region | GCC Countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain) Levant Region (Jordan, Lebanon, Iraq, Syria, Palestine) North Africa (Egypt, Libya, Sudan, Morocco, Algeria, Tunisia) Others |
| By Technology | Surgical instruments Cardiopulmonary bypass systems Imaging systems Anesthesia equipment Others |
| By Application | Elective surgeries Emergency surgeries Redo/repeat CABG Others |
| By Investment Source | Private funding Government funding International aid Others |
| By Policy Support | Government subsidies Tax incentives Grants for research and development Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Cardiac Surgeons in Major Hospitals | 60 | Cardiac Surgeons |
| Hospital Administrators | 50 | Hospital Administrators, Operations Managers |
| Patients Post-CABG | 40 | Patients, Caregivers |
| Medical Device Suppliers | 40 | Sales Representatives, Product Managers |
| Health Insurance Providers | 40 | Policy Analysts, Claims Managers |
The Middle East CABG Market is valued at approximately USD 520 million, reflecting a five-year historical analysis. This growth is driven by the rising prevalence of coronary artery diseases and advancements in surgical techniques.